Can prostate cancer be detected by a CT scan?

Written by Liu Liang
Oncology
Updated on November 16, 2024
00:00
00:00

If a CT scan is performed for prostate cancer, it usually can detect the tumor in the prostate, especially an enhanced CT scan will show enhancement. However, to confirm the diagnosis, it is still necessary to perform a prostate biopsy to find cancer cells. Only with the detection of cancer cells can prostate cancer be diagnosed. Additionally, a blood test for the tumor marker PSA, which generally increases, can be used in combination with these findings for a comprehensive evaluation. The definitive diagnosis of prostate cancer requires a biopsy to find cancer cells, which is the gold standard for diagnosing prostate cancer.

Other Voices

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
49sec home-news-image

The difference between benign prostatic hyperplasia and prostate cancer.

Prostatic hyperplasia and prostate cancer are sometimes very difficult to distinguish clinically, as both diseases occur in elderly men, can cause lower urinary tract symptoms, and lead to elevated PSA levels. However, prostatic hyperplasia generally has a longer medical history, whereas prostate cancer has a shorter history and progresses more quickly. During a digital rectal exam for prostatic hyperplasia, the gland appears enlarged and the surface is smooth. In contrast, during a prostate exam, the gland may show irregular enlargement, a rough surface, and the tumor feels firm. When these two are difficult to distinguish, considering a prostate biopsy may be advisable.

doctor image
home-news-image
Written by Liu Liang
Oncology
1min home-news-image

How long can one survive with prostate cancer?

The life expectancy of prostate cancer patients depends on the clinical stage at diagnosis, as well as the patient's sensitivity to various treatments such as endocrine therapy, chemotherapy, and radiotherapy. Patients diagnosed at earlier stages who are more responsive to treatment generally have better treatment outcomes and, consequently, a longer survival period compared to those who are diagnosed at later stages and have poor responses to treatment. Overall, prostate cancer patients tend to have a relatively long disease course, and the prognosis is generally good. Even patients with advanced prostate cancer exhibiting extensive bone metastasis can survive several years due to the effectiveness of endocrine treatments. The disease itself progresses slowly, so the prognosis for this type of cancer is comparatively favorable.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
27sec home-news-image

Late-stage prostate cancer with bone metastases: how long can one survive?

Bone metastasis is the most common site of metastasis for prostate cancer. If prostate cancer has metastasized to the bones, it means it is not in its early stages but has entered the advanced stages. However, this type of tumor is not like others with a higher degree of malignancy. If it has a good sensitivity to hormone therapy, after our standardized treatment, the survival time can still be quite long.

doctor image
home-news-image
Written by Liu Liang
Oncology
55sec home-news-image

Is prostate cancer radiotherapy painful?

Prostate cancer radiotherapy involves high doses of radiation, which typically results in related side effects. However, the severity of these side effects varies from patient to patient depending on individual factors such as their physical constitution. Therefore, clinically, some patients may experience severe symptoms, while others may have milder symptoms, indicating significant individual differences. Common side effects of radiotherapy include radiation cystitis, characterized by frequent urination, urgency, and possibly hematuria. Radiation proctitis is also common, presenting symptoms such as a sensation of heaviness around the anus and diarrhea. Additionally, bone marrow suppression, manifesting as a decrease in white blood cells and platelets, is another side effect.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 9sec home-news-image

Will prostate cancer embryonic antigen rise?

Prostate cancer is a common malignant tumor in the male urinary system. In some patients with prostate issues, there may be an increase in the carcinoembryonic antigen index in blood tests, but not all patients will exhibit this marker increase. Most prostate cancer patients will show an increase in the prostate-specific antigen (PSA) in blood tests, or there may be abnormal ratios of free PSA to bound PSA. Carcinoembryonic antigen and prostate-specific antigen are tumor markers for prostate cancer, but they only provide auxiliary value for diagnosis and do have some evaluative value regarding the effectiveness of anti-tumor treatment. Additionally, they can serve as a monitor for the condition of prostate cancer. Clinically, to confirm a diagnosis of prostate cancer, it is necessary to rely on the results of pathological tissue obtained through biopsy.